Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...
chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.
11d
A COLD snap due to descend on the UK this weekend could prove deadly for millions with a common health condition, a charity ...
Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...
The following is a summary of “Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary ...
The results of this comparative effectiveness research study suggest that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a ...
Image credit: Visual Vic/Getty Images. Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050. There are certain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback